Neuroimmunology of the interleukins 13 and 4

Brain Sciences

Volumn 6, Issue 2, 2016, Pages

  Mori, Simone ^a   Maher, Pamela ^b   Conti, Bruno ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Brain; Interleukin 13; Interleukin 4; Microglia; Neurodegeneration; Neuroinflammation; Neuron; Neuroprotection; Neurotoxic; Parkinson

Indexed keywords

4 AMINOBUTYRIC ACID; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; JANUS KINASE; LIPOPOLYSACCHARIDE; PHOSPHATIDYLINOSITOL 3 KINASE; STAT PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ALLERGIC REACTION; ALZHEIMER DISEASE; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; GENETIC POLYMORPHISM; HUMAN; IMMUNOMODULATION; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROIMMUNOLOGY; NEUROPROTECTION; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN EXPRESSION; SEX DIFFERENCE; SPATIAL LEARNING; TISSUE INJURY;

EID: 85015802419     PISSN: None     EISSN: 20763425     Source Type: Journal    
DOI: 10.3390/brainsci6020018     Document Type: Article

References (81)

1. Morrison, B.E., Marcondes, M.C., Nomura, D.K., Sanchez-Alavez, M., Sanchez-Gonzalez, A., Saar, I., Kim, K.S., Bartfai, T., Maher, P., Sugama, S., et al. Cutting edge: IL-13Rα1 expression in dopaminergic neurons contributes to their oxidative stress-mediated loss following chronic peripheral treatment with lipopolysaccharide. J. Immunol. 2012, 189, 5498-5502. [CrossRef] [PubMed]
2. Gibbs, B.F., Haas, H., Falcone, F.H., Albrecht, C., Vollrath, I.B., Noll, T., Wolff, H.H., Amon, U. Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation. Eur. J. Immunol. 1996, 26, 2493-2498. [CrossRef] [PubMed]
3. Haas, H., Falcone, F.H., Holland, M.J., Schramm, G., Haisch, K., Gibbs, B.F., Bufe, A., Schlaak, M. Early interleukin-4: Its role in the switch towards a Th2 response and IgE-mediated allergy. Int. Arch. Allergy Immunol. 1999, 119, 86-94. [CrossRef] [PubMed]
4. Howard, M., Paul, W.E. Interleukins for B lymphocytes. Lymphokine Res. 1982, 1, 1-4. [PubMed]
5. Jaffe, J.S., Raible, D.G., Post, T.J., Wang, Y., Glaum, M.C., Butterfield, J.H., Schulman, E.S. Human lung mast cell activation leads to IL-13 mRNA expression and protein release. Am. J. Respir. Cell Mol. Biol. 1996, 15, 473-481. [CrossRef] [PubMed]
6. Kim, E.Y., Battaile, J.T., Patel, A.C., You, Y., Agapov, E., Grayson, M.H., Benoit, L.A., Byers, D.E., Alevy, Y., Tucker, J., et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med. 2008, 14, 633-640. [CrossRef] [PubMed]
7. Lee, Y.C., Lee, K.H., Lee, H.B., Rhee, Y.K. Serum levels of interleukins (IL)-4, IL-5, IL-13, and interferon-gamma in acute asthma. J. Asthma 2001, 38, 665-671. [CrossRef] [PubMed]
8. McKenzie, A.N., Culpepper, J.A., de Waal Malefyt, R., Briere, F., Punnonen, J., Aversa, G., Sato, A., Dang, W., Cocks, G.B., Menon, S., et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc. Natl. Acad. Sci. USA 1993, 90, 3735-3739. [CrossRef] [PubMed]
9. Minty, A., Chalon, P., Derocq, J.M., Dumont, X., Guillemot, J.C., Kaghad, M., Labit, C., Leplatois, P., Liauzun, P., Miloux, B., et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993, 362, 248-250. [CrossRef] [PubMed]
10. Morgan, J.G., Dolganov, G.M., Robbins, S.E., Hinton, L.M., Lovett, M. The selective isolation of novel cDNAs encoded by the regions surrounding the human interleukin 4 and 5 genes. Nucleic Acids Res. 1992, 20, 5173-5179. [CrossRef] [PubMed]
11. Ochensberger, B., Daepp, G.C., Rihs, S., Dahinden, C.A. Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and -independent activation. Blood 1996, 88, 3028-3037. [PubMed]
12. Reglier, H., Arce-Vicioso, M., Fay, M., Gougerot-Pocidalo, M.A., Chollet-Martin, S. Lack of IL-10 and IL-13 production by human polymorphonuclear neutrophils. Cytokine 1998, 10, 192-198. [CrossRef] [PubMed]
13. Schmid-Grendelmeier, P., Altznauer, F., Fischer, B., Bizer, C., Straumann, A., Menz, G., Blaser, K., Wuthrich, B., Simon, H.U. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J. Immunol. 2002, 169, 1021-1027. [CrossRef] [PubMed]
14. Silvestri, M., Bontempelli, M., Giacomelli, M., Malerba, M., Rossi, G.A., Di Stefano, A., Rossi, A., Ricciardolo, F.L. High serum levels of tumour necrosis factor-α and interleukin-8 in severe asthma: Markers of systemic inflammation? Clin. Exp. Allergy 2006, 36, 1373-1381. [CrossRef] [PubMed]
15. Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T.Y., Karp, C.L., Donaldson, D.D. Interleukin-13: Central mediator of allergic asthma. Science 1998, 282, 2258-2261. [CrossRef] [PubMed]
16. Wong, C.K., Ho, C.Y., Ko, F.W., Chan, C.H., Ho, A.S., Hui, D.S., Lam, C.W. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin. Exp. Immunol. 2001, 125, 177-183. [CrossRef] [PubMed]
17. Wynn, T.A. IL-13 effector functions. Annu. Rev. Immunol. 2003, 21, 425-456. [CrossRef] [PubMed]
18. Brown, K.D., Zurawski, S.M., Mosmann, T.R., Zurawski, G. A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. J. Immunol. 1989, 142, 679-687. [PubMed]
19. Kuperman, D.A., Schleimer, R.P. Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma. Curr. Mol. Med. 2008, 8, 384-392. [CrossRef] [PubMed]
20. Wills-Karp, M. Interleukin-13 in asthma pathogenesis. Immunol. Rev. 2004, 202, 175-190. [CrossRef] [PubMed]
21. Chiba, N., Masuda, A., Yoshikai, Y., Matsuguchi, T. Ceramide inhibits LPS-induced production of IL-5, IL-10, and IL-13 from mast cells. J. Cell. Physiol. 2007, 213, 126-136. [CrossRef] [PubMed]
22. Galli, S.J., Gordon, J.R., Wershil, B.K. Cytokine production by mast cells and basophils. Curr. Opin. Immunol. 1991, 3, 865-872. [CrossRef]
23. Masuda, A., Yoshikai, Y., Aiba, K., Matsuguchi, T. Th2 cytokine production from mast cells is directly induced by lipopolysaccharide and distinctly regulated by c-Jun N-terminal kinase and p38 pathways. J. Immunol. 2002, 169, 3801-3810. [CrossRef] [PubMed]
24. Supajatura, V., Ushio, H., Nakao, A., Okumura, K., Ra, C., Ogawa, H. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J. Immunol. 2001, 167, 2250-2256. [CrossRef] [PubMed]
25. Aman, M.J., Tayebi, N., Obiri, N.I., Puri, R.K., Modi, W.S., Leonard, W.J. cDNA cloning and characterization of the human interleukin 13 receptor α chain. J. Biol. Chem. 1996, 271, 29265-29270. [PubMed]
26. Callard, R.E., Matthews, D.J., Hibbert, L. IL-4 and IL-13 receptors: Are they one and the same? Immunol. Today 1996, 17, 108-110. [CrossRef]
27. Hilton, D.J., Zhang, J.G., Metcalf, D., Alexander, W.S., Nicola, N.A., Willson, T.A. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 1996, 93, 497-501. [CrossRef] [PubMed]
28. Jiang, H., Harris, M.B., Rothman, P. IL-4/IL-13 signaling beyond JAK/STAT. J. Allergy Clin. Immunol. 2000, 105 Pt 1, 1063-1070. [CrossRef] [PubMed]
29. Leonard, W.J., O’Shea, J.J. Jaks and STATs: Biological implications. Annu. Rev. Immunol. 1998, 16, 293-322. [CrossRef] [PubMed]
30. Lin, J.X., Migone, T.S., Tsang, M., Friedmann, M., Weatherbee, J.A., Zhou, L., Yamauchi, A., Bloom, E.T., Mietz, J., John, S., et al. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 1995, 2, 331-339. [CrossRef]
31. Nelms, K., Keegan, A.D., Zamorano, J., Ryan, J.J., Paul, W.E. The IL-4 receptor: Signaling mechanisms and biologic functions. Annu. Rev. Immunol. 1999, 17, 701-738. [CrossRef] [PubMed]
32. Orchansky, P.L., Ayres, S.D., Hilton, D.J., Schrader, J.W. An interleukin (IL)-13 receptor lacking the cytoplasmic domain fails to transduce IL-13-induced signals and inhibits responses to IL-4. J. Biol. Chem. 1997, 272, 22940-22947. [CrossRef] [PubMed]
33. Caput, D., Laurent, P., Kaghad, M., Lelias, J.M., Lefort, S., Vita, N., Ferrara, P. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain. J. Biol. Chem. 1996, 271, 16921-16926. [PubMed]
34. Donaldson, D.D., Whitters, M.J., Fitz, L.J., Neben, T.Y., Finnerty, H., Henderson, S.L., O’Hara, R.M., Beier, D.R., Turner, K.J., Wood, C.R., et al. The murine IL-13 receptor α2: Molecular cloning, characterization, and comparison with murine IL-13 receptor α1. J. Immunol. 1998, 161, 2317-2324. [PubMed]
35. Feng, N., Lugli, S.M., Schnyder, B., Gauchat, J.F., Graber, P., Schlagenhauf, E., Schnarr, B., Wiederkehr-Adam, M., Duschl, A., Heim, M.H., et al. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: Overexpression of the nonsignaling interleukin-13 receptor α2. Lab. Investig. 1998, 78, 591-602. [PubMed]
36. Liu, H., Jacobs, B.S., Liu, J., Prayson, R.A., Estes, M.L., Barnett, G.H., Barna, B.P. Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: Non-neoplastic glia and low-grade astrocytoma differ from malignant glioma. Cancer Immunol. Immunother. 2000, 49, 319-324. [CrossRef] [PubMed]
37. Debinski, W., Gibo, D.M., Hulet, S.W., Connor, J.R., Gillespie, G.Y. Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas. Clin. Cancer Res. 1999, 5, 985-990. [PubMed]
38. Sengupta, S., Thaci, B., Crawford, A.C., Sampath, P. Interleukin-13 receptor α 2-targeted glioblastoma immunotherapy. Biomed. Res. Int. 2014, 2014, 952128. [CrossRef] [PubMed]
39. Haque, S.J., Wu, Q., Kammer, W., Friedrich, K., Smith, J.M., Kerr, I.M., Stark, G.R., Williams, B.R. Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1. Proc. Natl. Acad. Sci. USA 1997, 94, 8563-8568. [CrossRef] [PubMed]
40. Johnson, L.N., Noble, M.E., Owen, D.J. Active and inactive protein kinases: Structural basis for regulation. Cell 1996, 85, 149-158. [CrossRef]
41. Hou, J., Schindler, U., Henzel, W.J., Ho, T.C., Brasseur, M., McKnight, S.L. An interleukin-4-induced transcription factor: IL-4 Stat. Science 1994, 265, 1701-1706. [CrossRef] [PubMed]
42. Mikita, T., Campbell, D., Wu, P., Williamson, K., Schindler, U. Requirements for interleukin-4-induced gene expression and functional characterization of Stat6. Mol. Cell. Biol. 1996, 16, 5811-5820. [CrossRef] [PubMed]
43. Schindler, U., Wu, P., Rothe, M., Brasseur, M., McKnight, S.L. Components of a Stat recognition code: Evidence for two layers of molecular selectivity. Immunity 1995, 2, 689-697. [CrossRef]
44. Bhattacharjee, A., Shukla, M., Yakubenko, V.P., Mulya, A., Kundu, S., Cathcart, M.K. IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radic. Biol. Med. 2013, 54, 1-16. [CrossRef] [PubMed]
45. Darnell, J.E., Kerr, I.M., Stark, G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264, 1415-1421. [CrossRef] [PubMed]
46. Mandal, D., Fu, P., Levine, A.D. REDOX regulation of IL-13 signaling in intestinal epithelial cells: Usage of alternate pathways mediates distinct gene expression patterns. Cell. Signal. 2010, 22, 1485-1494. [CrossRef] [PubMed]
47. Bluthe, R.M., Bristow, A., Lestage, J., Imbs, C., Dantzer, R. Central injection of interleukin-13 potentiates LPS-induced sickness behavior in rats. Neuroreport 2001, 12, 3979-3983. [CrossRef] [PubMed]
48. Shin, W.H., Lee, D.Y., Park, K.W., Kim, S.U., Yang, M.S., Joe, E.H., Jin, B.K. Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo. Glia 2004, 46, 142-152. [CrossRef] [PubMed]
49. Yang, M.-S., Ji, K.-A., Jeon, S.-B., Jin, B.-K., Kim, S.U., Jou, N., Joe, E. Interleukin-13 enhances cyclooxygenase-2 expression in activated rat brain microglia: Implications for death of activated microglia. J. Immunol. 2006, 177, 1323-1329. [CrossRef] [PubMed]
50. Yang, M.S., Park, E.J., Sohn, S., Kwon, H.J., Shin, W.H., Pyo, H.K., Jin, B., Choi, K.S., Jou, I., Joe, E.H. Interleukin-13 and -4 induce death of activated microglia. Glia 2002, 38, 273-280. [CrossRef] [PubMed]
51. Yasuda, Y., Shimoda, T., Uno, K., Tateishi, N., Furuya, S., Yagi, K., Suzuki, K., Fujita, S. The effects of MPTP on the activation of microglia/astrocytes and cytokine/chemokine levels in different mice strains. J. Neuroimmunol. 2008, 204, 43-51. [CrossRef] [PubMed]
52. Yu, J.T., Lee, C.H., Yoo, K.Y., Choi, J.H., Li, H., Park, O.K., Yan, B., Hwang, I.K., Kwon, Y.G., Kim, Y.M., et al. Maintenance of anti-inflammatory cytokines and reduction of glial activation in the ischemic hippocampal CA1 region preconditioned with lipopolysaccharide. J. Neurol. Sci. 2010, 296, 69-78. [CrossRef] [PubMed]
53. Zhao, X., Wang, H., Sun, G., Zhang, J., Edwards, N.J., Aronowski, J. Neuronal interleukin-4 as a modulator of microglial pathways and ischemic brain damage. J. Neurosci. 2015, 35, 11281-11291. [CrossRef] [PubMed]
54. Latta, C.H., Sudduth, T.L., Weekman, E.M., Brothers, H.M., Abner, E.L., Popa, G.J., Mendenhall, M.D., Gonzalez-Oregon, F., Braun, K., Wilcock, D.M. Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice. J. Neuroinflamm. 2015, 12, 41. [CrossRef] [PubMed]
55. Xiong, X., Xu, L., Wei, L., White, R.E., Ouyang, Y.B., Giffard, R.G. IL-4 is required for sex differences in vulnerability to focal ischemia in mice. Stroke 2015, 46, 2271-2276. [CrossRef] [PubMed]
56. Lee, H.J., Park, H.J., Starkweather, A., An, K., Shim, I. Decreased interleukin-4 release from the neurons of the Locus Coeruleus in response to immobilization stress. Med. Inflamm. 2016, 2016, 3501905. [CrossRef] [PubMed]
57. Conti, B. The Scripps Research Institute, CA, USA. Unpublished work, 2016.
58. Nam, J.H., Park, K.W., Park, E.S., Lee, Y.B., Lee, H.G., Baik, H.H., Kim, Y.S., Maeng, S., Park, J., Jin, B.K. Interleukin-13/-4-induced oxidative stress contributes to death of hippocampal neurons in aβ1-42-treated hippocampus in vivo. Antioxid. Redox Signal. 2012, 16, 1369-1383. [CrossRef] [PubMed]
59. Park, K.W., Baik, H.H., Jin, B.K. Interleukin-4-induced oxidative stress via microglial NADPH oxidase contributes to the death of hippocampal neurons in vivo. Curr. Aging Sci. 2008, 1, 192-201. [CrossRef] [PubMed]
60. Park, K.W., Baik, H.H., Jin, B.K. IL-13-induced oxidative stress via microglial NADPH oxidase contributes to death of hippocampal neurons in vivo. J. Immunol. 2009, 183, 4666-4674. [CrossRef] [PubMed]
61. Yadav, M.C., Burudi, E.M., Alirezaei, M., Flynn, C.C., Watry, D.D., Lanigan, C.M., Fox, H.S. IFN-gamma-induced IDO and WRS expression in microglia is differentially regulated by IL-4. Glia 2007, 55, 1385-1396. [CrossRef] [PubMed]
62. Clarke, R.M., Lyons, A., O’Connell, F., Deighan, B.F., Barry, C.E., Anyakoha, N.G., Nicolaou, A., Lynch, M.A. A pivotal role for interleukin-4 in atorvastatin-associated neuroprotection in rat brain. J. Biol. Chem. 2008, 283, 1808-1817. [CrossRef] [PubMed]
63. Deboy, C.A., Xin, J., Byram, S.C., Serpe, C.J., Sanders, V.M., Jones, K.J. Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4(+) T cells. Exp. Neurol. 2006, 201, 212-224. [CrossRef] [PubMed]
64. Rossi, S., Mancino, R., Bergami, A., Mori, F., Castelli, M., De Chiara, V., Studer, V., Mataluni, G., Sancesario, G., Parisi, V., et al. Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis. Mult. Scler. J. 2011, 17, 1301-1312. [CrossRef] [PubMed]
65. Won, S.Y., Kim, S.R., Maeng, S., Jin, B.K. Interleukin-13/Interleukin-4-induced oxidative stress contributes to death of prothrombinkringle-2 (pKr-2)-activated microglia. J. Neuroimmunol. 2013, 265, 36-42. [CrossRef] [PubMed]
66. Bluthe, R.M., Lestage, J., Rees, G., Bristow, A., Dantzer, R. Dual effect of central injection of recombinant rat interleukin-4 on lipopolysaccharide-induced sickness behavior in rats. Neuropsychopharmacology 2002, 26, 86-93. [CrossRef]
67. Linker, R.A., Sendtner, M., Gold, R. Mechanisms of axonal degeneration in EAE—Lessons from CNTF and MHC I knockout mice. J. Neurol. Sci. 2005, 233, 167-172. [CrossRef] [PubMed]
68. Zeis, T., Graumann, U., Reynolds, R., Schaeren-Wiemers, N. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 2008, 131, 288-303. [CrossRef] [PubMed]
69. Seyfizadeh, N., Kazemi, T., Farhoudi, M., Reza Aliparasti, M., Sadeghi-Bazargani, H., Almasi, S., Babaloo, Z. Association of IL-13 single nucleotide polymorphisms in Iranian patients to multiple sclerosis. Am. J. Clin. Exp. Immunol. 2014, 3, 124-129. [PubMed]
70. Rozsa, K.S., Rubakhin, S.S., Szucs, A., Hughes, T.K., Stefano, G.B. Opposite effects of interleukin-2 and interleukin-4 on GABA-induced inward currents of dialysed lymnaea neurons. Gen. Pharmacol. 1997, 29, 73-77. [CrossRef]
71. Sanna, A., Fois, M.L., Arru, G., Huang, Y.M., Link, H., Pugliatti, M., Rosati, G., Sotgiu, S. Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis. Clin. Exp. Immunol. 2006, 143, 357-362. [CrossRef] [PubMed]
72. Cash, E., Minty, A., Ferrara, P., Caput, D., Fradelizi, D., Rott, O. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J. Immunol. 1994, 153, 4258-4267. [PubMed]
73. Offner, H., Subramanian, S., Wang, C., Afentoulis, M., Vandenbark, A.A., Huan, J., Burrows, G.G. Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury. J. Immunol. 2005, 175, 4103-4111. [CrossRef] [PubMed]
74. Young, D.A., Lowe, L.D., Booth, S.S., Whitters, M.J., Nicholson, L., Kuchroo, V.K., Collins, M. IL-4, IL-10, IL-13, and TGF- β from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. J. Immunol. 2000, 164, 3563-3572. [CrossRef] [PubMed]
75. Ochoa-Repáraz, J., Rynda, A., Ascón, M.A., Yang, X., Kochetkova, I., Riccardi, C., Callis, G., Trunkle, T., Pascual, D.W. IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen. J. Immunol. 2008, 181, 954-968. [CrossRef] [PubMed]
76. Compston, A., Coles, A. Multiple sclerosis. Lancet 2008, 372, 1502-1517. [CrossRef]
77. Sinha, S., Kaler, L.J., Proctor, T.M., Teuscher, C., Vandenbark, A.A., Offner, H. IL-13-mediated gender difference in susceptibility to autoimmune encephalomyelitis. J. Immunol. (Baltim. Md. 1950) 2008, 180, 2679-2685. [CrossRef]
78. Verdu, E.F., Deng, Y., Bercik, P., Collins, S.M. Modulatory effects of estrogen in two murine models of experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 283, 27-36. [CrossRef] [PubMed]
79. Kawahara, K., Suenobu, M., Yoshida, A., Koga, K., Hyodo, A., Ohtsuka, H., Kuniyasu, A., Tamamaki, N., Sugimoto, Y., Nakayama, H. Intracerebral microinjection of interleukin-4/interleukin-13 reduces β-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice. Neuroscience 2012, 207, 243-260. [CrossRef] [PubMed]
80. Man (OMIM) database. Available online: http://www.omim.org (accessed on 9 June 2016).
81. Frank-Cannon, T.C., Tran, T., Ruhn, K.A., Martinez, T.N., Hong, J., Marvin, M., Hartley, M., Trevino, I., O’Brien, D.E., Casey, B., et al. Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. J. Neurosci. 2008, 28, 10825-10834. [CrossRef] [PubMed]